Tablet Health Tirzepatide Review: Intro Price & Renewal Rules

Tablet Health’s compounded tirzepatide injection page lists $129.99 for the first month, then $199.99 per month. It also lists $499.99 for a three-month plan and $1,099.99 for a six-month plan. The introductory amount is not the ongoing monthly price. Confirm the amount due now and the renewal schedule for the selected plan.³

Compare the full plan, not only the first month

The oral tirzepatide page displays the same three price options. That does not make oral and injected preparations clinically interchangeable. Confirm the prescribed formulation, dose, supplied quantity and total with the clinician; the menu alone does not establish your eligibility or prescription.^3,4

The multi-month labels describe plan totals, but do not clearly establish whether those amounts are collected upfront or in installments. Nor do they explain why two three-month plans would total $999.98 while the six-month plan is $1,099.99. Ask which offer, inclusions and renewal price apply rather than assuming the longer commitment is cheapest.³

Cancellation can require action before the renewal date

The terms say some products automatically renew on the schedule disclosed at checkout. The first renewal may be charged early, and later shipments may be charged and sent up to three days early. To stop renewal, cancellation is required at least three days before the applicable renewal processing date; cancellation takes effect at the end of the current period.⁵

That processing date matters more than an expected delivery date. The terms do not generally refund partially used subscription periods, although discretionary case-by-case exceptions are possible. A paused plan resumes automatically if it is not canceled before the pause ends. The separate no-refund clause says applicable fees and charges are nonrefundable in whole or in part.⁵

The refund FAQ says personalized prescription products cannot be returned and directs patients to support for review of available options. It does not promise a universal refund if treatment is unsuitable, ineffective or discontinued. Obtain the specific nonapproval, cancellation and medication-fulfillment terms before paying.⁶

Separate the platform, clinical care and pharmacy

Tablet’s terms identify a separate medical group, spelled “Berluga Health,” and say Tablet is not the healthcare provider. Its pharmacy directory lists The Pharmacy Hub, Epiq Scripts, Dr. TelX LLC and Emerald Compounding Pharmacy. The Pharmacy Hub entry includes an ED-prescription label; the directory does not establish that every listed partner prepares tirzepatide or will fill your prescription.^5,7

The terms permit transfers between partner pharmacies and say assignment depends on geography and availability, unless an appropriate alternative is arranged with the clinician. The page footer identifies TABLET TELEHEALTH CORP., while the telehealth consent identifies Tablet LLC. Confirm the billing entity, actual treating practice and preparing/dispensing facility for your plan. A directory listing is not verification of current credentials or a patient-specific assignment.^5,7,8

Brand-drug trials do not establish outcomes for this platform or its compounded preparations, including the advertised oral option. SURMOUNT-1 and SURMOUNT-5 provide clinical context rather than proof of Tablet’s product or service.^1,2

Confirm your location’s availability, selected formulation, complete payment schedule and governing agreement before paying.

Further reading

whether compounded tirzepatide is still legal in 2026, Zepbound side effects, the gallbladder risk, thyroid cancer warning, tirzepatide evidence guide, TeleClinic, Ondra Health, best tirzepatide providers.